Drugs / UQSC2
last change Dec 2023 re-read 9 days ago

UQSC2

Vaccine

Developed for
COVID-19
Investigated by
Coalition for Epidemic Preparedness Innovations · The University of Queensland

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05775887 May → Dec 2023 COVID-19 The University of Queensland Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as UQSC2 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05775887 ↗
Modality Vaccine “UQSC2 vaccine” NCT05775887 ↗